Alopecia Areata (AA)Atopic
Dermatitis (AD)
Psoriatic
Arthritis (PsA)
Rheumatoid
Arthritis (RA)
Ulcerative
Colitis (UC)
Ankylosing
Spondylitis (AS)

Pfizer Personal Empowerment Portal

Ankylosing Spondylitis

Patient-centered Tools for Education & Engagement

Pfizer is committed to helping people with ankylosing spondylitis (AS) become empowered to play an important role in managing their medical condition. What does personal empowerment mean? It is a process that may help patients work with their medical team to act on medical and lifestyle issues that they, together, define as important. Empowerment means becoming a partner with the healthcare professional (HCP) team to participate in shared decision-making on personal treatment-related issues and options.

The following brochurecreated by Pfizer Medical Affairsprovides important content for adult patients who have AS. The brochure:

  • Offers insights for adult patients into the characteristics of AS and how it can be managed
  • Provides disease-related information that can be used to educate family members or friends about AS
  • Can help support the Treat-to-Target (T2T) approach to care based on shared decision-making

Ankylosing Spondylitis: Disease Diagnosis and Management Materials

Personal empowerment begins with patients understanding how AS can be diagnosed and managed. This brochure provides a helpful overview of AS, including disease characteristics and some ways to manage it.

Understanding Ankylosing Spondylitis Disease Activity in Adults...Above and Below the Surface

This brochure provides basic information about ankylosing spondylitis, including disease characteristics and disease-management approaches.

Download English version PDF

The health information in this site is provided for educational purposes only and is not intended to replace discussions with a healthcare provider.
All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.

This site is intended only for US residents.